Endolymphatic Hydrops Reversal following Acetazolamide Therapy: Demonstration with Delayed Intravenous Contrast-Enhanced 3D-FLAIR MRI

References

1. 1.↵
   1. Baloh RW,
   2. Halmagyi GM

   2. Andrews JC,
   3. Honrubia V

   . Menière's disease. In: Baloh RW, Halmagyi GM, eds. Disorders of the Vestibular System. New York: Oxford University Press; 1996: 300–17
2. 2.↵
   1. Harris JP

   2. Paparella MM,
   3. Sajjadi H

   . The natural history of Menière's disease. In: Harris JP, ed. Menière's Disease. Amsterdam: Kugler Publications; 1999:29–40
3. 3.↵
   2. Chung JW,
   3. Fayad J,
   4. Linthicum F, et al

   . Histopathology after endolymphatic sac surgery for Ménière's syndrome. Otol Neurotol 2011;32:660–64 doi:10.1097/MAO.0b013e31821553ce pmid:21436748

   CrossRefPubMed
4. 4.↵
   2. Paparella MM

   . Pathogenesis and pathophysiology of Menière's disease. Acta Otolaryngol Suppl 1991;485:26–35 pmid:1843169

   PubMed
5. 5.↵
   2. Merchant SN,
   3. Adams JC,
   4. Nadol JB Jr.

   . Pathophysiology of Menière's syndrome: are symptoms caused by endolymphatic hydrops? Otol Neurotol 2005;26:74–81 doi:10.1097/00129492-200501000-00013 pmid:15699723

   CrossRefPubMedWeb of Science
6. 6.↵
   2. Pyykko I,
   3. Nakashima T,
   4. Yoshida T, et al

   . Menière's disease: a reappraisal supported by a variable latency of symptoms and the MRI visualisation of endolymphatic hydrops. BMJ Open 2013;3:pii: e001555 doi:10.1136/bmjopen-2012-001555 pmid:23418296

   Abstract/FREE Full Text
7. 7.↵
   2. Baráth K,
   3. Schuknecht B,
   4. Naldi AM, et al

   . Detection and grading of endolymphatic hydrops in Menière disease using MR imaging. AJNR Am J Neuroradiol 2014;35:1387–92 doi:10.3174/ajnr.A3856 pmid:24524921

   Abstract/FREE Full Text
8. 8.↵
   2. Sepahdari AR,
   3. Ishiyama G,
   4. Vorasubin N, et al

   . Delayed intravenous contrast-enhanced 3D FLAIR MRI in Menière's disease: correlation of quantitative measures of endolymphatic hydrops with hearing. Clin Imaging 2015;39:26–31 doi:10.1016/j.clinimag.2014.09.014 pmid:25457542

   CrossRefPubMed
9. 9.↵
   2. Gürkov R,
   3. Flatz W,
   4. Keeser D, et al

   . Effect of standard-dose betahistine on endolymphatic hydrops: an MRI pilot study. Eur Arch Otorhinolaryngol 2013;270:1231–35 doi:10.1007/s00405-012-2087-3 pmid:22760844

   CrossRefPubMed
10. 10.↵
    2. Liu F,
    3. Huang W,
    4. Meng X, et al

    . Comparison of noninvasive evaluation of endolymphatic hydrops in Menière's disease and endolymphatic space in healthy volunteers using magnetic resonance imaging. Acta Otolaryngol 2012;132:234–40 doi:10.3109/00016489.2011.637232 pmid:22201445

    CrossRefPubMed
11. 11.↵
    Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Menière's disease: American Academy of Otolaryngology-Head and Neck Foundation, Inc. Otolaryngol Head Neck Surg 1995;113:181–85 doi:10.1016/S0194-5998(95)70102-8 pmid:7675476

    FREE Full Text
12. 12.↵
    2. Naganawa S,
    3. Yamazaki M,
    4. Kawai H, et al

    . Visualization of endolymphatic hydrops in Ménière's disease with single-dose intravenous gadolinium-based contrast media using heavily T(2)-weighted 3D-FLAIR. Magn Reson Med Sci 2010;9:237–42 doi:10.2463/mrms.9.237 pmid:21187694

    CrossRefPubMed
13. 13.↵
    2. Naganawa S,
    3. Nakashima T

    . Visualization of endolymphatic hydrops with MR imaging in patients with Ménière's disease and related pathologies: current status of its methods and clinical significance. Jpn J Radiol 2014;32:191–204 doi:10.1007/s11604-014-0290-4 pmid:24500139

    CrossRefPubMed
14. 14.↵
    2. Mukaida T,
    3. Sone M,
    4. Yoshida T, et al

    . Magnetic resonance imaging evaluation of endolymphatic hydrops in cases with otosclerosis. Otol Neurotol 2015;36:1146–50 doi:10.1097/MAO.0000000000000685 pmid:25522197

    CrossRefPubMed